ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong Press release Key Updates August 28, 2017
Lilly and ProQR to Expand RNA Editing Collaboration Press release New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology December 22, 2022
ProQR Appoints ADAR Expert Dr. Peter A. Beal to Scientific Advisory Board to Focus on Axiomer® RNA A-to-I Editing Technology Press release Key Updates April 10, 2018
ProQR Announces Results for the Third Quarter of 2016 Press release LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2016
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 Press release LEIDEN, Netherlands, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 26, 2015
ProQR Announces Results for the Second Quarter of 2016 Press release LEIDEN, the Netherlands, Aug. 17, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 17, 2016